New Approach to Phospholipidosis Prediction

磷脂沉积症预测的新方法

• 批准号: 8715281
• 负责人: PIOTR W RZEPECKI
• 金额: $ 44.94万
• 依托单位: ECHELON BIOSCIENCES, INC.
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-01 至 2016-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8715281
• 关键词: New; Approach; Phospholipidosis; Prediction

DESCRIPTION (provided by applicant): Drug safety is a major concern for pharmaceutical groups, regulatory bodies, basic researchers and particularly patients. Safe and effective drugs maximize successful clinical outcomes and patient compliance. This project will provide unique tools for detecting drugs that have potential to induce the dangerous outcome phospholipidosis early in the drug development process and will identify patients that may be susceptible to this dangerous adverse event.

描述（由申请人提供）：药物安全性是制药集团、监管机构、基础研究人员，特别是患者的主要关注点。安全有效的药物最大限度地提高成功的临床结果和患者依从性。该项目将提供独特的工具，用于在药物开发过程的早期检测有可能诱导危险结局磷脂质病的药物，并将识别可能易受这种危险不良事件影响的患者。